RedHill Biopharma’s Opaganib Awarded COVID-19 Grant by State of Pennsylvania
A global Phase 2/3 study in up to 270 patients hospitalized with severe COVID-19 pneumonia, and a U.S. Phase 2 […]
A global Phase 2/3 study in up to 270 patients hospitalized with severe COVID-19 pneumonia, and a U.S. Phase 2 […]
Patent challenge initiated by Bausch Health CompaniesNESS ZIONA, Israel, Sept. 03, 2020 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), […]
BARRIE, Ontario, Sept. 03, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or […]
RESEARCH TRIANGLE PARK, N.C., Sept. 03, 2020 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the U.S. Department […]
AUSTIN, Texas, Sept. 03, 2020 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that it has been […]
– Reported Positive Topline Pre-Specified Interim Results from PROTECTIVE-2 (Study 106) Phase 3, Demonstrating Plinabulin’s Superiority in Combination with Neulasta […]
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company […]
ImmunoRank Offers a Faster, Simpler, More Cost Effective Way to Identify High Titer Convalescent Plasma for Use in Both Treating […]
Late Quarter Rebound in Automotive SalesCost Saving Actions Partially Reduced COVID-19 Pandemic ImpactElectric and Hybrid Vehicle Programs IncreasingCHICAGO, Sept. 03, […]
New AEM VTEM Plus survey with state of the art equipment and processing to be flown over Alexo-Dundonald. More detailed AEM […]